Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 29, 2021
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
[ Fri, Jan 29th 2021
] - WOPRAI
Eric Joseph Downgraded (AKBA) to Sell on, Jan 29th, 2021
Eric Joseph of JP Morgan, Downgraded "Akebia Therapeutics, Inc." (AKBA) to Sell on, Jan 29th, 2021.
Eric has made no other calls on AKBA in the last 4 months.
There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Eric's Rating of Hold.
This is the rating of the analyst that currently disagrees with Eric
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Monday, October 26th, 2020
